Latest News and Press Releases

TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...

The Garneau Titanium Project Features Ilmenite-Rich Boulder with Grab-Sample Assays of 65.1% Fe₂O₃, 32.4% TiO₂, and 2,260 ppm Vanadium

TORONTO, March 25, 2026 (GLOBE NEWSWIRE) -- Partners Value Split Corp. (the “Company”, TSX: PVS.PR.H, PVS.PR.J, PVS.PR.K, PVS.PR.L, PVS.PR.M, PVS.PR.U, PVS.PR.V) announced today its financial...

All amounts are in Canadian dollars unless otherwise stated This Transaction provides Boralex with powerful levers to accelerate the execution of its 2030 Strategic Plan and strengthens its ability...

This Transaction provides Boralex with powerful levers to accelerate the execution of its 2030 Strategic Plan and strengthens its ability to create long-term value for all its stakeholders.Boralex...

New York City, NY, March 24, 2026 (GLOBE NEWSWIRE) -- Gelatide is at the forefront of a significant shift in the dietary supplement landscape, as consumers increasingly move away from traditional...

American Fusion Inc. (OTC: AMFN) Appoints Michael Carlson as Chief Financial Officer

CALGARY, Alberta, March 23, 2026 (GLOBE NEWSWIRE) -- TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) is pleased to host its 2026 Investor Day today, in Toronto and virtually....

Entered agreement to acquire a portfolio of brands with revenue of $200 million and EBITDA of $95 millionBreathe Right is an iconic and category‑leading brand with strong margins and cash flow...

- Duchenne (SGT-003): Positive interim Phase 1/2 INSPIRE DUCHENNE data reported at the 2026 MDA Annual Meeting continued to suggest differentiated clinical, safety and tolerability profiles; SGT-003...